
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR JULY 2025
|
|
Net to Trust Sales |
|
|
||||||
|
|
Volumes (a) |
|
Average Price (a) |
||||||
|
|
Oil (bbls) |
|
Gas (Mcf) |
|
Oil (per bbl) |
|
Gas (per Mcf) |
||
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
||
Current Month |
|
42,748 |
|
940,600 |
|
$65.46 |
|
$3.24 |
||
|
|
|
|
|
|
|
|
|
||
Prior Month |
|
58,818 |
|
1,004,988 |
|
$67.59 |
|
$3.22 |
||
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
(a) Sales volumes are recorded in the month the Trust receives and identifies the related royalty income. Because of this, sales volumes and pricing may fluctuate from month to month based on the timing of cash receipts.
Revenues are only distributed after they are received, verified, and posted. Most energy companies normally issue payment of royalties on or about the 25th of every month, and depending on mail delivery, a varying amount of royalties are not received until after the revenue posting on the last business day of the month. The revenues received after that date will be posted within 30 days of receipt.
Due to the timing of the end of the month of June, approximately $505,000 of revenue received will be posted in the following month of July in addition to normal cash receipts received during July. Since the close of business in June and prior to this press release, approximately $5,273,000 in revenue has been received.
The 2024 Annual Report with Form 10-K and the December 31, 2024, Reserve Summary are available on the Sabine website at .
Forward-looking Statements
Any statements in this press release about future events or conditions, and other statements containing the words "estimates," "believes," "anticipates," "plans," "expects," "will," "may," "intends" and similar expressions, other than historical facts, constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Factors or risks that could cause the Trust's actual results to differ materially from the results the Trustee anticipates include, but are not limited to the factors described in Part I, Item 1A, "Risk Factors" of the Trust's Annual Report on Form 10-K for the year ended December 31, 2024, and Part II, Item 1A, "Risk Factors" of subsequently filed Quarterly Reports on Form 10-Q.
Actual results may differ materially from those indicated by such forward-looking statements. In addition, the forward-looking statements included in this press release represent the Trustee's views as of the date hereof. The Trustee anticipates that subsequent events and developments may cause its views to change. However, while the Trustee may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Trustee's views as of any date subsequent to the date hereof.
SOURCE Sabine Royalty Trust
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Everstake Brings Ethereum Experts Together To Explore Post-Pectra And Institutional Adoption
- Bitget Adds AINUSDT To Futures Trading With Bot Integration
- Nominis Wins 'Product Innovation Award' At Mastercard Fintech Finals In Berlin
- BSGM Engages CXG To Acquire FINRA/SEC-Registered Broker-Dealer To Expand Publicly Traded RWA Tokenization Operations
- First Trust Financials Alphadex Becomes The Largest Shareholders Of Freedom Holding After Timur Turlov
- Primexbt Rolls Out Major Platform Upgrades And Enhanced Trading Conditions
Comments
No comment